Since 2014, we have reliably been supplying hospital, pathology and research laboratories with Bioporto Diagnostics products for testing and diagnostic purposes. Our industry-standard supply chain ensures that we meet your requirements. We are happy to provide technical advice and answer your enquiries pertaining to the applications of Bioporto products.
The Company’s flagship products are based on the NGAL biomarker and designed to aid in the risk assessment and diagnosis of Acute Kidney Injury (AKI), a common clinical syndrome that can have severe consequences, including significant morbidity and mortality, if not identified and treated early. With the aid of NGAL levels, physicians can identify patients potentially at risk of AKI more rapidly than is possible with current standard of care measurements, enabling earlier intervention and more tailored patient management strategies.
Use this form to send us a message.
*All fields are required.
